PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

Clinical trial NCT06409936 · RECRUITING

Trial details

NCT number: NCT06409936
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

CML, Chronic Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia, BCR/ABL-Positive Chronic Myeloid Leukemia

Start date: 2025-06-26
Primary completion: 2029-06-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.